SCHEMBL29503634

SCHEMBL29503634

CSc1ncc2cc(Br)c(NCC3CC3)nc2n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 12/20 0.34
▸ AKT2 P31751 12/20 0.34
▸ IRAK1 P51617 2/20 0.34
▸ PRKCQ Q04759 3/20 0.33
▸ USP7 Q93009 1/20 0.33
▸ PPARG P37231 1/20 0.32
▸ TRPM8 Q7Z2W7 1/20 0.32
▸ PRKD3 O94806 1/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ PIM1 P11309 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ MAPK9 P45984 1/20 0.32
▸ CSNK1D P48730 1/20 0.32
▸ CLK2 P49760 1/20 0.32
▸ GSK3A P49840 1/20 0.32
▸ GSK3B P49841 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24271449 1.00 AKT1 (0.34) AKT1AKT2IRAK1PRKCQUSP7
SCHEMBL25272086 0.95 PPARG (0.37) AKT1AKT2IRAK1PPARG
SCHEMBL25278070 0.81 CYP1A2 (0.40) AKT1AKT2CYP3A4CYP2D6
SCHEMBL25227024 0.80 AKT1 (0.39) AKT1AKT2CYP3A4CYP2D6CDK2
SCHEMBL29536669 0.80 AKT1 (0.39) AKT1AKT2CYP3A4CYP2D6CDK2
SCHEMBL4076223 0.79 PPARG (0.43) PPARG
SCHEMBL29536658 0.79 AKT1 (0.39) AKT1AKT2PRKD3MAP4K4CDK1
SCHEMBL25271560 0.79 AKT1 (0.39) AKT1AKT2PRKD3MAP4K4CDK1
SCHEMBL29537498 0.78 AKT1 (0.34) AKT1AKT2CSNK2A1
SCHEMBL25271264 0.78 AKT1 (0.34) AKT1AKT2CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4211119-A1 2-AMINOQUINAZOLINES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF Merck Sharp & Dohme LLC (US) 2023-07-19 — — EP disclosed
WO-2022051337-A1 2-AMINOQUINAZOLINES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME CORP. (US) 2022-03-10 — — WO disclosed
Send feedback